The anti-cocaine vaccine, developed by researchers at the Federal University of Minas Gerais, Brazil, aims to produce antibodies that bind to cocaine when it is taken. This would make it harder for the substance to pass through the bloodstream to the brain. The vaccine would try to inhibit the brain reactions that trigger the craving.
Latest News
19:36
European food products are praised for quality but score lower on value for money, survey in 11 countries shows
19:35
The government approves new hires at Romgaz, Nuclearelectrica Serv and Hidroserv for energy projects and maintenance activities
19:25
The former administrator of the cemetery in Slatina is accused of moving bodies into mass graves in order to free up burial plots
19:18
Meteorologists have issued a Yellow Code warning for storms, hail, and strong winds in 18 localities in Moldova
19:09
The European Parliament approves faster authorizations for the defense industry and the simplification of military procurement
See more news